Your browser doesn't support javascript.
loading
A rare, potentially life-threatening presentation of passenger lymphocyte syndrome.
Gniadek, Thomas J; McGonigle, Andrea M; Shirey, R Sue; Brunker, Patricia A; Streiff, Michael; Philosophe, Benjamin; Bloch, Evan M; Ness, Paul M; King, Karen E.
Afiliação
  • Gniadek TJ; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota.
  • McGonigle AM; Department of Pathology and Laboratory Medicine, Wing-Kwai and Alice Lee-Tsing Chung Transfusion Service, David Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Shirey RS; Department of Pathology, Division of Transfusion Medicine, Johns Hopkins Hospital, Baltimore, Maryland.
  • Brunker PA; Department of Pathology, Division of Transfusion Medicine, Johns Hopkins Hospital, Baltimore, Maryland.
  • Streiff M; American Red Cross, Greater Chesapeake & Potomac Region, Baltimore, Maryland.
  • Philosophe B; Department of Medicine, Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Bloch EM; Department of Surgery, Division of Transplantation, Johns Hopkins Hospital, Baltimore, Maryland.
  • Ness PM; Department of Pathology, Division of Transfusion Medicine, Johns Hopkins Hospital, Baltimore, Maryland.
  • King KE; Department of Pathology, Division of Transfusion Medicine, Johns Hopkins Hospital, Baltimore, Maryland.
Transfusion ; 57(5): 1262-1266, 2017 May.
Article em En | MEDLINE | ID: mdl-28369969
ABSTRACT

BACKGROUND:

Passenger lymphocyte syndrome occurs when donor lymphocytes are transplanted with a solid organ and produce alloantibodies that react with antigens on the recipient's red blood cells (RBCs). Typically, passenger lymphocyte syndrome presents as immunoglobulin G antibody-mediated, extravascular hemolytic anemia with reticulocytosis. Often, the donor was alloimmunized before transplantation. CASE REPORT A 34-year-old Group O, D+ man with a negative antibody screen received a liver transplant from a Group O, D- donor. Twenty Group O, D+ RBC units were transfused on Postoperative Days (PODs) 0 through 2. On POD 7, the patient developed anemia, a weakly positive antibody screen, and a positive direct antiglobulin test with anti-D in the eluate. After POD 8, a D- transfusion protocol was initiated. Despite laboratory evidence of hemolysis, two initial peripheral blood smears showed no increase in schistocytes or spherocytes, the reticulocyte count was depressed, and a marrow biopsy revealed erythroid hyperplasia. Eventually, anemia resolved after a period of medication non-compliance; however, a positive direct antiglobulin test persisted to the last follow-up date (POD 233).

RESULTS:

Other potential causes of aplastic anemia were investigated, but no alternative cause was found. History excluded passive anti-D. D+, LW- cells were reactive, excluding anti-LW. Genotyping showed no evidence of a partial D genotype. Chart review revealed that the liver donor had a history of anti-D. A diagnosis of passenger lymphocyte syndrome was reached.

CONCLUSION:

Although antibody-mediated hemolytic anemia has been reported to cause reticulocytopenia in the presence of marrow erythroid hyperplasia, this report of passenger lymphocyte syndrome causing a similar post-transplant anemia in association with reticulocytopenia is noteworthy.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Incompatibilidade de Grupos Sanguíneos / Linfócitos / Transplante de Fígado / Anemia Hemolítica Tipo de estudo: Guideline Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Incompatibilidade de Grupos Sanguíneos / Linfócitos / Transplante de Fígado / Anemia Hemolítica Tipo de estudo: Guideline Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article